Delisting riskPopularity #3,943
HOWL · NASDAQ · Biotechnology

Werewolf Therapeutics (HOWL)

Develops conditionally activated cytokine and T-cell-engager therapies for cancer.

$0.9760
vs last close−0.01 (−0.61%)